Top 25 van geneesmiddelen die het sterkst zijn gestegen in de vergoeding in 2022
- Raming voor de totale Zvw-populatie
| ATC-code | Vergoeding 2022 |
Vergoeding 2021 |
absolute toename t.o.v. 2021 |
procentuele toename t.o.v. 2021 |
|
|---|---|---|---|---|---|
| 1 | R07AX02 Ivacaftor (Kalydeco ®) | 75.053.000 | 37.385.800 | 37.667.200 | 100.75% |
| 2 | N07XX08 Tafamidis (Vyndaqel ®) | 26.855.300 | 3.545.500 | 23.309.800 | 657.45% |
| 3 | B01AF02 Apixaban (Eliquis ®) | 113.391.300 | 93.343.000 | 20.048.300 | 21.48% |
| 4 | C09DX04 Valsartan met sacubitril (Entresto ®) | 49.495.000 | 29.710.400 | 19.784.600 | 66.59% |
| 5 | A10BJ06 Semaglutide (Ozempic ®) | 54.934.500 | 36.169.000 | 18.765.500 | 51.88% |
| 6 | A10BK01 Dapagliflozine (Forxiga ®) | 21.032.600 | 5.403.600 | 15.629.000 | 289.23% |
| 7 | B01AF01 Rivaroxaban (Xarelto ®) | 111.884.900 | 100.546.900 | 11.338.000 | 11.28% |
| 8 | C10AX13 Evolocumab (Repatha ®) | 66.453.700 | 55.537.900 | 10.915.800 | 19.65% |
| 9 | C10AX14 Alirocumab (Praluent ®) | 58.353.900 | 47.665.500 | 10.688.400 | 22.42% |
| 10 | J06BA02 Immunoglobuline normaal intravasculair (Nanogam ®) | 84.186.800 | 74.482.700 | 9.704.100 | 13.03% |
| 11 | A10BJ02 Liraglutide (Victoza ®) | 17.689.100 | 9.275.700 | 8.413.400 | 90.70% |
| 12 | A10BK03 Empagliflozine (Jardiance ®) | 12.390.600 | 4.115.700 | 8.274.900 | 201.06% |
| 13 | N02CD01 Erenumab (Aimovig ®) | 7.011.800 | 562.850 | 6.448.950 | 1145.77% |
| 14 | J05AR20 Emtricitabine met tenofoviralafenamide en bictegravir (Biktarvy ®) | 34.595.400 | 28.509.200 | 6.086.200 | 21.35% |
| 15 | L01EX09 Nintedanib (Ofev ®) | 23.088.000 | 17.404.500 | 5.683.500 | 32.66% |
| 16 | N02CD02 Galcanezumab (Emgality ®) | 6.625.900 | 1.029.100 | 5.596.800 | 543.85% |
| 17 | R03AL09 Formoterol met glycopyrroniumbromide en beclometason (Trimbow ®) | 20.880.300 | 15.329.800 | 5.550.500 | 36.21% |
| 18 | J05AR25 Lamivudine met dolutegravir (Dovato ®) | 17.124.100 | 11.691.500 | 5.432.600 | 46.47% |
| 19 | L04AA40 Cladribine (Mavenclad ®) | 10.281.400 | 5.276.500 | 5.004.900 | 94.85% |
| 20 | N02CD03 Fremanezumab (Ajovy ®) | 5.343.500 | 352.570 | 4.990.930 | 1415.59% |
| 21 | B06AC01 C1-esteraseremmer uit plasma (Cinryze ®) | 10.173.400 | 5.243.000 | 4.930.400 | 94.04% |
| 22 | M09AX03 Ataluren (Translarna ®) | 4.811.600 | 9.205 | 4.802.395 | 52171.6% |
| 23 | R03AK08 Formoterol met beclometason (Foster ®) | 54.470.000 | 49.842.500 | 4.627.500 | 9.28% |
| 24 | B01AF03 Edoxaban (Lixiana ®) | 32.172.500 | 27.756.200 | 4.416.300 | 15.91% |
| 25 | N06BA02 Dexamfetamine (Tentin ®) | 20.340.200 | 16.744.600 | 3.595.600 | 21.47% |